EUVIMEDEUVIMED entdecken
EditorialKommentar

Lessons learned from the COVID ‐19 pandemic and future pandemic preparedness for children in Japan

Yusuke Okubo iD

Pediatrics International · 2024

DOI: 10.1111/ped.15732 ↗

Kurz gefasst

Editorial in der Zeitschrift Pediatrics International, 2024. Verfasst von Yusuke Okubo. Beteiligte Einrichtung: Department of Social Medicine, National Center for Child Health and Development, Tokyo, Japan. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit nennt 5 Literaturangaben. Gefördert von: Precursory Research for Embryonic Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The coronavirus disease-2019 (COVID-19), caused by severe acute respiratory syndrome virus 2 (SARS-CoV-2), was initially detected in Wuhan, China, in December 2019 and rapidly disseminated worldwide.1 In Japan, the first case of COVID-19 was recorded in January 2020. The spread of COVID-19 to Japanese children was relatively slow as the infections predominantly occurred among adults during the early phase of the pandemic, and the Japanese government implemented infection prevention measures in educational institutions, which were widely adhered to.2 The cumulative numbers of newly confirmed COVID-19 cases among children 12 years in June 2021, those aged 5–11 years in March 2022, and those aged 6 months to 4 years in October 2022 with recommendations from the Japan Pediatric Society and the Japanese Pediatric Association. However, the vaccination rates ended up very low, especially for younger children. Several factors may have contributed to the lower vaccination rates, such as factors of guardian's decision-making and fear of adverse reactions, and these have been addressed in recent issues of the Journal. Korematsu et al.4 explored factors affecting guardian's decision-making toward the SARS-CoV-2 vaccine and discussed the perspectives. Guardians who vaccinated their children at least once highly valued the spread of COVID-19 and the availability of free vaccination. In contrast, those who did not vaccinate their children focus on concerns about adverse reactions and seek specific data on vaccine effectiveness in Japan. Matsumoto et al.5 investigated adverse reactions among younger children who received their primary doses of BNT162b2. They reported that adverse reactions, including fever, were infrequent and were not associated with a history of COVID-19, but were associated with co-administration of seasonal influenza vaccine. These findings highlight the necessity of a robust system to collect timely data on vaccine efficacy and safety for children. While randomized controlled trials may not be feasible during an unprecedented pandemic, real-world vaccine effectiveness and safety measures can be estimated through well-designed cohort studies or case–control studies, such as test-negative case–control design. Because Japanese people tend to be cautious toward newly introduced vaccinations, often influenced by media and other external pressures, policymakers and healthcare workers need domestic data to provide comprehensive explanations to guardians and children timely. Establishing such a robust strategy is essential for future pandemic planning and preparedness. Dr Okubo drafted the initial manuscript, approved the final manuscript as submitted, and takes full responsibility for its contents. Yusuke Okubo was supported by the grant from the Japan Science and Technology Agency (PRESTO: JPMJPR22R4). The authors have no conflicts of interest relevant to this article to disclose. The authors have no financial relationships relevant to this article to disclose.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19ChildHumansPandemic PreparednessJapanPandemicsSARS-CoV-2

Autor:innen und Institutionen

  • Department of Social Medicine, National Center for Child Health and Development, Tokyo, Japan.

ORCID-Profile: Yusuke Okubo

Förderung

  • Precursory Research for Embryonic Science and Technology

Zitieren

APA

Okubo, Y. (2024). Lessons learned from the COVID ‐19 pandemic and future pandemic preparedness for children in Japan. Pediatrics International. https://doi.org/10.1111/ped.15732

Vancouver

Okubo Y. Lessons learned from the COVID ‐19 pandemic and future pandemic preparedness for children in Japan. Pediatrics International. 2024. doi:10.1111/ped.15732

BibTeX
@article{Okubo2024,
  author = {Okubo, Yusuke},
  title = {Lessons learned from the COVID ‐19 pandemic and future pandemic preparedness for children in Japan},
  journal = {Pediatrics International},
  year = {2024},
  doi = {10.1111/ped.15732}
}
Kostenlos starten →